Errik Anderson

Co-Founder, Adimab

Founder and CEO at Alloy Therapeutics

Hanover, New Hampshire

About

Male

Errik Anderson is based out of Hanover, New Hampshire and is the Founder, CEO and Chairman of Alloy Therapeutics. Errik previously worked at Major League Rugby as a Chairman of the Board of Governors. Errik Anderson attended the Dartmouth College.

Experience

Alloy Therapeutics

Founder and CEO

View →

Growth134Waltham, Massachusetts, United StatesBiotech/Pharma · Biopharma

Board Member · Mytide Therapeutics
2022 – present
Co-Founder and Owner · New England Free Jacks
2018 – present
Co-Founder, President/COO · Compass Therapeutics
2013 – present
Founder and Managing Partner · Ulysses Diversified Holdings
2013 – present
Co-Founder · Alector
2013 – present
Co-Founder and former Board Member · Avitide
2012 – present
Board Member · Wingu
2011 – present
Co-Founder and Former Board Member · Arsanis
2010 – present
Co-Founder · Adimab
2007 – present
Board Member · Cantai Therapeutics
Board of Directors · Vernal Biosciences
Board Of Directors · WelbeHealth

Education

Tuck School of Business at Dartmouth College · MBA
2003 – 2007
Dartmouth College · A.B, Economics
1996 – 2000

Headlines from Google News. Social posts load from the platform only when you open a tab.

Alloy Therapeutics secures $1B valuation
The Business Journals · Jun 29
Alloy Therapeutics: $40 Million Series E At $1 Billion Valuation Raised To Scale AI-Driven Biotech Infrastructure
Pulse 2.0 · Apr 19
Boost for Cambridge as US company Alloy Therapeutics shows real Vigilance
Business Weekly · Apr 8
Biogen links up with Alloy platform to boost ASO drug development
Fierce Biotech · Apr 7
Dartmouth’s Inaugural Innovation Summit: Shaping the Future of Healthcare and Technology
Geisel School of Medicine at Dartmouth · Oct 4

People at Alloy Therapeutics

Christian Cobaugh

Chief Executive Officer of Genetic Medicines Division

Alaa Halawa

Investor

John Lippincott

Senior Vice President Therapeutic Discovery Strategies

Data from: crunchbase